Sainmhíniú clinical effectiveness of a medicinal product compared with other treatments Tagairt "COM-Terminology Coordination, based on: Communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions - A Stronger European-based Pharmaceutical Industry for the Benefit of the Patient - A Call for Action, COM(2003) 383"
Nóta There is no universally agreed definition of major therapeutic advantage or added therapeutic value, and different stakeholders (medical journals, HTA bodies, payers) apply different definitions according to their remit: some of these consider parameters that go beyond the current legal framework for medicines.